Correlation Between Cyteir Therapeutics and XOMA
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and XOMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and XOMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and XOMA Corporation, you can compare the effects of market volatilities on Cyteir Therapeutics and XOMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of XOMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and XOMA.
Diversification Opportunities for Cyteir Therapeutics and XOMA
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cyteir and XOMA is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and XOMA Corp. in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XOMA and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with XOMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XOMA has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and XOMA go up and down completely randomly.
Pair Corralation between Cyteir Therapeutics and XOMA
If you would invest 2,475 in XOMA Corporation on September 5, 2024 and sell it today you would earn a total of 71.00 from holding XOMA Corporation or generate 2.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
Cyteir Therapeutics vs. XOMA Corp.
Performance |
Timeline |
Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
XOMA |
Cyteir Therapeutics and XOMA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyteir Therapeutics and XOMA
The main advantage of trading using opposite Cyteir Therapeutics and XOMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, XOMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will offset losses from the drop in XOMA's long position.Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |